144 related articles for article (PubMed ID: 11107147)
21. Strong uptake of 111In-pentetreotide by an MIBG-negative, xenografted neuroblastoma.
Manil L; Perdereau B; Barbaroux C; Brixy F
Int J Cancer; 1994 Apr; 57(2):245-6. PubMed ID: 7908895
[TBL] [Abstract][Full Text] [Related]
22. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
23. [Scintigraphic diagnosis of neuroblastoma using meta-iodobenzylguanidine].
Kimmig B; Brandeis WE; Eisenhut M; Ludwig R; Adolph J
Klin Padiatr; 1986; 198(3):224-9. PubMed ID: 3723986
[TBL] [Abstract][Full Text] [Related]
24. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
El-Maghraby T
Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
[TBL] [Abstract][Full Text] [Related]
25. Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors.
Limouris GS; Giannakopoulos V; Stavraka A; Toubanakis N; Vlahos L
Anticancer Res; 1997; 17(3B):1589-92. PubMed ID: 9179199
[TBL] [Abstract][Full Text] [Related]
26. The impact of 123I-meta-iodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma.
Abrahamsen J; Lyck B; Helgestad J; Frederiksen PB
Acta Oncol; 1995; 34(4):505-10. PubMed ID: 7605659
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the utility of
Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
[TBL] [Abstract][Full Text] [Related]
28. Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
Asnacios A; Courbon F; Rochaix P; Bauvin E; Cances-Lauwers V; Susini C; Schulz S; Boneu A; Guimbaud R; Buscail L
J Clin Oncol; 2008 Feb; 26(6):963-70. PubMed ID: 18281671
[TBL] [Abstract][Full Text] [Related]
29. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
Rozovsky K; Koplewitz BZ; Krausz Y; Revel-Vilk S; Weintraub M; Chisin R; Klein M
AJR Am J Roentgenol; 2008 Apr; 190(4):1085-90. PubMed ID: 18356459
[TBL] [Abstract][Full Text] [Related]
30. [123I-metaiodobenzylguanidine (MIBG) scintigraphy for the staging of neuroblastoma].
Okuyama C; Ushijima Y; Sugihara H; Okitsu S; Maeda T
Kaku Igaku; 1998 Nov; 35(9):835-42. PubMed ID: 9916399
[TBL] [Abstract][Full Text] [Related]
31. Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.
Suc A; Lumbroso J; Rubie H; Hattchouel JM; Boneu A; Rodary C; Robert A; Hartmann O
Cancer; 1996 Feb; 77(4):805-11. PubMed ID: 8616776
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
Hero B; Hunneman DH; Gahr M; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):220-3. PubMed ID: 11464889
[TBL] [Abstract][Full Text] [Related]
33. (123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial.
Vik TA; Pfluger T; Kadota R; Castel V; Tulchinsky M; Farto JC; Heiba S; Serafini A; Tumeh S; Khutoryansky N; Jacobson AF
Pediatr Blood Cancer; 2009 Jul; 52(7):784-90. PubMed ID: 19185008
[TBL] [Abstract][Full Text] [Related]
34. MIBG and radiolabeled octreotide in neuroendocrine tumors.
Hoefnagel CA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):137-9. PubMed ID: 9002773
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of postoperative 123I-metaiodobenzylguanidine scintigraphy: added value of SPECT/CT and semiquantification of the uptake at the surgical site.
Gauthé M; Breton M; Jehanno N; Cellier C; Michon J; Sarnacki S; Schleiermacher G; Wartski M
Q J Nucl Med Mol Imaging; 2020 Mar; 64(1):131-138. PubMed ID: 29409315
[TBL] [Abstract][Full Text] [Related]
36. Radio-iodobenzylguanidine scintigraphy of neuroblastoma: conflicting results, when compared with standard investigations.
Schmiegelow K; Simes MA; Agertoft L; Berglund G; Storm-Mathisen I; Andreassen M; Salmi TT; Nygård R; Wiebe T; Kreuger A
Med Pediatr Oncol; 1989; 17(2):127-30. PubMed ID: 2649775
[TBL] [Abstract][Full Text] [Related]
37. [Metaiodobenzylguanidine scintigraphy in the diagnosis and followup of neuroblastoma. Apropos of 16 cases].
Hammami H; Hassine L; Mhiri A; Sellem A; Oubich F; Gharssallah L; Barsaoui S; Ben Brahim H
Tunis Med; 2007 May; 85(5):413-6. PubMed ID: 17657930
[TBL] [Abstract][Full Text] [Related]
38. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.
Hoefnagel CA
Eur J Nucl Med; 1994 Jun; 21(6):561-81. PubMed ID: 7915987
[TBL] [Abstract][Full Text] [Related]
39. Utility of follow-up studies using meta-[123 I]iodobenzylguanidine scintigraphy for detecting recurrent neuroblastoma.
Okuyama C; Ushijima Y; Kubota T; Nakamura T; Kikkawa M; Nishimura T
Nucl Med Commun; 2002 Jul; 23(7):663-72. PubMed ID: 12089489
[TBL] [Abstract][Full Text] [Related]
40. Specificity of radioiodinated MIBG for neural crest tumors in childhood.
Leung A; Shapiro B; Hattner R; Kim E; de Kraker J; Ghazzar N; Hartmann O; Hoefnagel CA; Jamadar DA; Kloos R; Lizotte P; Lumbroso J; Rufini V; Shulkin BL; Sisson JC; Thein A; Troncone L
J Nucl Med; 1997 Sep; 38(9):1352-7. PubMed ID: 9293786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
